Home Newsfeeds Guggenheim Downgrades Neoleukin Therapeutics to Neutral

Guggenheim Downgrades Neoleukin Therapeutics to Neutral

Guggenheim analyst Michael Schmidt downgrades Neoleukin Therapeutics (NASDAQ:NLTX) from Buy to Neutral.

byBenzinga Newsdesk

November 15, 2022

1 minute read

Guggenheim analyst Michael Schmidt downgrades Neoleukin Therapeutics (NASDAQ:NLTX) from Buy to Neutral.

Movers
News

Why Peloton Shares Are Backpedaling Thursday

By Adam Eckert

May 11, 10:46 AM

Peloton Interactive Inc (NASDAQ: PTON) shares are trading lower Thursday after the U.S. Consumer Product Safety Commission announced the recall of two million exercise bikes due to fall and injury hazards.

PTON

News

Digi International Selects MaxLinear PCIe Bridges And Serial Transceivers For Integration Into Digi Connect Console Access Servers

By Benzinga Newsdesk

September 1, 8:37 AM

Flexibility of Wide Serial-Port Expansion Easily Scales to Meet Connectivity Requirements MaxLinear Inc. (NASDAQ:MXL) today announced that Digi International (NASDAQ:DGII), a global leader in IoT connectivity

DGII

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

January 18, 2:25 PM

Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.

ACGN

News

Evolv Technology Surpasses 1B Visitors Screened

By Benzinga Newsdesk

November 13, 9:22 AM

– Pressing need for improved security combined with innovative screening solutions and trusted customer partnerships drive Evolv's continued industry-leading position –Evolv Technology (NASDAQ:EVLV), the leader in

EVLV

Guggenheim Downgrades Neoleukin Therapeutics to Neutral

Related Posts

Why Peloton Shares Are Backpedaling Thursday

Digi International Selects MaxLinear PCIe Bridges And Serial Transceivers For Integration Into Digi Connect Console Access Servers

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

Evolv Technology Surpasses 1B Visitors Screened